Primary Job Title Independent Director, Chairman of the Board Primary Organization 
Durata Therapeutics
Gender Male
Richard U. De Schutter has served as chairman of our board of directors since April 2012.
Mr. De Schutter has been the chairman of the board of directors of Incyte Corporation since 2004.
Mr. De Schutter previously served as chairman of the board of directors and Chief Executive Officer of DuPont Pharmaceuticals Company, Chief
Administrative Officer of Pharmacia Corporation, Vice Chairman and Chief Administrative Officer of Monsanto Company and Chief Executive Officer of G.D. Searle & Co.
Mr. De Schutter also serves as a member of the board of directors of Smith and Nephew plc and several privately held companies.
He also served as a member of board of directors of Ecolab, Inc. from 2004 to 2010 and Varian, Inc. from 2001 until its acquisition by Agilent Technologies, Inc. in 2010.
Mr. De Schutter holds a B.S. and an M.S. in Chemical Engineering from the University of Arizona, and completed the Executive Management program at Columbia Business School.
We believe that Mr. De Schutter’s career in the pharmaceutical industry, including extensive experience as an executive and service on the boards of directors of other biopharmaceutical companies, gives him the qualifications and skills to serve as a director.
